SG/PUT/NOVO-NORDISK B/650/0.1/21.03.25 Share Price

Warrant

DE000SW8RNJ2

Market Closed - Bid/Ask 07:07:21 03/07/2024 BST After market 19:00:05
0.17 EUR +6.25% Intraday chart for SG/PUT/NOVO-NORDISK B/650/0.1/21.03.25 0.22 +29.41%
1 month-44.83%
Date Price Change
03/07/24 0.17 +6.25%
02/07/24 0.16 0.00%
01/07/24 0.16 0.00%
28/06/24 0.16 -5.88%
27/06/24 0.17 +6.25%

Delayed Quote Börse Stuttgart

Last update July 03, 2024 at 07:07 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
IssuerLogo Issuer Société Générale Société Générale
WKN SW8RNJ
ISINDE000SW8RNJ2
Date issued 09/04/2024
Strike 650 kr
Maturity 21/03/2025 (261 Days)
Parity 10 : 1
Emission price 0.53
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.55
Lowest since issue 0.16
Delta0x
Omega 0.000000
Premium0x
Gearing58.9x
Moneyness 0.6718
Difference Strike -317.5 kr
Difference Strike %-48.85%
Spread 0.02
Spread %8.70%
Intrinsic value 0.000000
Present value 0.2200

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
993.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-4.16%
Consensus